1. Obesity causes inflammation which increases DNMT1 expression and activity, leading to DNA hypermethylation of the adiponectin gene promoter and reduced adiponectin expression.
2. Inhibition of DNMT with RG108 prevents obesity-induced hypermethylation of the adiponectin gene, increasing adiponectin levels and improving insulin resistance.
3. RG108 treatment in obese mice reduces adiponectin gene hypermethylation, elevates adiponectin levels, and improves glucose tolerance and insulin signaling without affecting body weight or organ function.
5. Plasma adiponectin levels have also been reported to be reduced in obese humans, particularly those with
visceral obesity, and to correlate inversely with insulin resistance. Prospective and longitudinal studies have
shown that lower adiponectin levels are associated with a higher incidence of diabetes.
Adiponectin and Adiponectin Receptors. Endocrine Reviews 26(3):439–451.
6. Result1: Adiponectin promoter is hypermethylated
in obese subjects.
脂联素水平发现显著改变,而脂联素调节因子表达水平变化
无统计学差异。
检测脂联素启动子区域的甲基化水平(BSP法)
?
7. Result1:Adiponectin promoter is hypermethylated in obese subjects.
R2 R1
1.在高脂饮食以及db/db鼠中R2区域明显高甲基化
2.脂联素mRNA表达量与甲基化水平负相关
1.R1区域无明显变化
2.未见相关性
11. Result3:Inflammatory cytokines promote DNA methylation at the R2.
pro-inflammatory cytokines
endoplasmic reticulum stress
mitochondrial dysfunction
hypoxicenvironment
DNMT relative enzymatic
activity.
10 ng/m,24h
10 ng/m,24h
Although the above factors potently suppressed
adiponectin gene expression, only pro-inflammatory
cytokines such as tumour necrosis factor (TNFα) and
interleukin (IL)-1β were able to induce Dnmt1 expression
and activity
13. Result4:DNMT inhibition alleviates the effect of TNFα on adiponectin.
RG108, a DNMT inhibitor.
In adipocytes, RG108 decreased TNFα-induced
DNMT1 activity, while Dnmt1 mRNA level was
elevated by TNFα
14. Result4:DNMT inhibition alleviates the effect of TNFα on adiponectin.
In 3T3-L1 adipocytes, DNMT1 was
suppressed by small interfering RNA.
The cells were then incubated with
or without TNFα (10 ng/ml) for 24 h
(n=3).
mRNA levels of adiponectin, Dnmt1
and Mcp-1 in negative control (NC)
or DNMT1 suppressed 3T3-L1
adipocytes.
Quantification of the 5-
mC levels in the
adiponectin promoter R2
and R1.
15. Result5:RG108 elevates adiponectin levels by the reduction of R2 DNA
methylation in db/db mice.
(vehicle , 1% DMSO)
WAT
Serum
R2 DNA methylation levels
血清脂联素低聚复合物的相对水平
Correlation between R2 DNA methylation and adiponectin mRNA levels
16. Result6:RG108 improves insulin resistance via adiponectin expression.
OGTT. After 16 h fasting Area under the curve (AUC)
Western blot of insulin signalling in liver (d) and skeletal muscle(e)
HE染色 eWAT/liver
lipogenic genes in the liver
17. Result6:RG108 improves insulin resistance via adiponectin expression.
adiponectin and leptin receptor double knockout (DKO) mice
liver,HE
18. RG108 does not influence the body weight, organ weight, and liver function in db/db and adiponectin and
leptin receptor knockout (DKO) mice and cannot suppress adipose tissue inflammation in DKO mice
19. In obesity, increased DNMT1 induces DNA hypermethylation at the particular region (R2) of
adiponectin promoter,resulting in suppression of adiponectin gene expression in adipocytes
Differentiated adipocytes were challenged with several stimuli suppressing adiponectin expression, including pro-inflammatory cytokines, endoplasmic reticulum stress, mitochondrial dysfunction or hypoxicenvironment22,23,24. Although the above factors potently suppressed adiponectin gene expression, only pro-inflammatory cytokines such as tumour necrosis factor (TNFα) and interleukin (IL)-1β were able to induce Dnmt1 expression and activity (Fig. 3a,b and Supplementary Fig. 4a
2.Further, NF-κB signalling pathway appeared to be engaged in cytokine-induced stimulation of DNMT1 as treatment of Bay-11–7082 (BAY), an inhibitor of NF-κB, substantially reduced the level of DNMT1 expression induced by TNFα
补充图片7:RG108 does not influence body weight, organ weight, and DNA
methylation at the R1 in adipocytes, at the R2 in the liver or at the promoters of several genes
related with inflammation in SVCs of db/db mice